In Vitro Maturation Special Interest Group (IVMSIG)

Over the past decade, there have been a growing number of publications in peer-reviewed journals on the use of oocyte in-vitro maturation (IVM) treatment in clinical settings worldwide. The underlying trend seems to be the need for alternative, low-burden reproductive treatment options for specific groups of infertile or subfertile patients. At the same time, there has been an increased uptake of IVM as an appended technology in the setting of fertility preservation for cancer patients. IVMSIG strives to define the best strategies to optimize IVM outcomes.

You can join the In Vitro Maturation Special Interest Group when you join ASRM. (How to Join an ASRM Member Group)